Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants

Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants

Abstract Background Evidence of adverse clinical outcomes for non-vitamin K antagonist oral anticoagulant (NOACs) and warfarin in patients with atrial fibrillation (AF) and diabetes mellitus are limited. We investigated the effectiveness, safety, and major adverse limb events for NOACs versus warfar...

Full description

Bibliographic Details
Main Authors: Yi-Hsin Chan, Hsin-Fu Lee, Pei-Ru Li, Jia-Rou Liu, Tze-Fan Chao, Lung-Sheng Wu, Shang-Hung Chang, Yung-Hsin Yeh, Chi-Tai Kuo, Lai-Chu See, Gregory Y. H. Lip
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Cardiovascular Diabetology
Subjects:
Atrial fibrillation
Diabetes mellitus
Ischemic stroke
Major bleeding
NOACs
Warfarin
Online Access:http://link.springer.com/article/10.1186/s12933-020-01043-2

Internet

http://link.springer.com/article/10.1186/s12933-020-01043-2

Similar Items